GliaPharm is a Swiss-based biotechnology company that develops treatments for neurological and psychiatric disorders.. Founded in 2016, GliaPharm is backed by investors that include MassChallenge and Gliaven and is headquartered in Geneva.
FOUNDED:
2016
INDUSTRY:
Biotechnology
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
